Study of Five Different Methods Of Delivering A Lifestyle Modification Program for Weight Loss
Public ClinicalTrials.gov record NCT00471172. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 6-Month, Randomized Study To Evaluate The Efficacy Of Various Non-Pharmacologic, Disease Management Programs For The Treatment Of Obesity
Study identification
- NCT ID
- NCT00471172
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Pfizer
- Industry
- Enrollment
- 350 participants
Conditions and interventions
Conditions
Interventions
- Face-to-face counseling by a dietitian (months 1-3: weekly, months 4-6: every other week) Behavioral
- Face-to-face counseling by a dietitian (monthly) Behavioral
- Counseling by a dietitian via telephone (months 1-3: weekly, months 4-6: every other week) Behavioral
- Counseling by a dietitian via e-mail (months 1-3: weekly, months 4-6: every other week) Behavioral
- Self help Behavioral
Behavioral
Eligibility (public fields only)
- Age range
- 25 Years to 60 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2004
- Primary completion
- Not listed
- Completion
- Apr 30, 2005
- Last update posted
- Sep 14, 2008
2004 – 2005
United States locations
- U.S. sites
- 12
- U.S. states
- 9
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Pfizer Investigational Site | Los Angeles | California | — | — |
| Pfizer Investigational Site | Clearwater | Florida | — | — |
| Pfizer Investigational Site | Kissimmee | Florida | — | — |
| Pfizer Investigational Site | Pembroke Pines | Florida | — | — |
| Pfizer Investigational Site | Lexington | Kentucky | — | — |
| Pfizer Investigational Site | Louisville | Kentucky | — | — |
| Pfizer Investigational Site | Milford | Massachusetts | — | — |
| Pfizer Investigational Site | Charlotte | North Carolina | — | — |
| Pfizer Investigational Site | Harleysville | Pennsylvania | — | — |
| Pfizer Investigational Site | Warwick | Rhode Island | — | — |
| Pfizer Investigational Site | Nashville | Tennessee | — | — |
| Pfizer Investigational Site | Milwaukee | Wisconsin | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00471172, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 14, 2008 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00471172 live on ClinicalTrials.gov.